MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 04
18-02-2010
STS Xp22 Steroid Sulfatase gene (STS)
Vs. 07
09-12-2012
STS Xp22 Steroid Sulfatase gene (STS)
Vs. 08
23-07-2013
STS Xp22 Steroid Sulfatase gene (STS)
Vs. 09
22-09-2016
STS Xp22 Steroid Sulfatase gene (STS)
Vs. 13
10-11-2011
GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) Hearing loss
P163-D1 Vs. 14 09-12-2012 GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) Hearing loss
P163-D1 Vs. 15 22-07-2015 GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) Hearing loss
P163-D1 Vs. 16 16-12-2015 GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) Hearing loss
P163-D1 Vs. 17 28-04-2017 GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) Hearing loss
P163-D1 Vs. 18 28-09-2017 GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) Hearing loss
Vs. 23
11-06-2008
IDS Xq28 Mucopolysaccharidosis type II, or Hunter syndrome
Vs. 08
01-05-2010
IDS Xq28 Mucopolysaccharidosis type II, or Hunter syndrome
Vs. 11
28-03-2014
IDS Xq28 Mucopolysaccharidosis type II, or Hunter syndrome
Vs. 21
23-10-2011
SPG3A 14q21, SPAST 2p22 Spastic paraplegia, hereditary (HSP)
P165-C1 Vs. 22 09-12-2012 SPG3A 14q21, SPAST 2p22 Spastic paraplegia, hereditary (HSP)
P165-C1 Vs. 23 22-07-2015 SPG3A 14q21, SPAST 2p22 Spastic paraplegia, hereditary (HSP)
P165-C2 Vs. 24 11-11-2015 SPG3A 14q21, SPAST 2p22 Spastic paraplegia, hereditary (HSP)
Vs. 04
09-12-2009
KCNQ2 20q13.33 Benign familial neonatal convulsion (BFNC)
Vs. 05
11-07-2011
KCNQ2 20q13.33 Benign familial neonatal convulsion (BFNC)
Vs. 07
20-12-2012
KCNQ2 20q13.33 Benign familial neonatal convulsion (BFNC)
Vs. 08
15-07-2015
KCNQ2 20q13.33 Benign familial neonatal convulsion (BFNC)
Vs. 09
05-11-2015
KCNQ2 20q13.33 Benign familial neonatal convulsion (BFNC)
Vs. 06
16-05-2011
DSP 6p24, PKP2 12q11.21 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Vs. 07
23-10-2011
DSP 6p24, PKP2 12q11.21 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Vs. 08
09-12-2012
DSP 6p24, PKP2 12q11.21 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Vs. 09
09-07-2013
DSP 6p24, PKP2 12q11.21 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Vs. 10
13-03-2015
DSP 6p24, PKP2 12q11.21 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Vs. 11
25-07-2016
DSP 6p24, PKP2 12q11.21 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Vs. 06
25-09-2008
RET 10q11.2, ZFHX1B 2q22.3, EDN3 20q13.3 and GDNF 5q13.2 Hirschsprung disease, or Aganglionic Megacolon
P169-B1 Vs.08 30-10-2011 RET 10q11.2, ZFHX1B 2q22.3, EDN3 20q13.3 and GDNF 5q13.2 Hirschsprung disease, or Aganglionic Megacolon
P169-C1 Vs.10 18-03-2013 RET 10q11.2, ZFHX1B 2q22.3, EDN3 20q13.3 and GDNF 5q13.2 Hirschsprung disease, or Aganglionic Megacolon
P169-C2 Vs.12 12-11-2015 RET 10q11.2, ZFHX1B 2q22.3, EDN3 20q13.3 and GDNF 5q13.2 Hirschsprung disease, or Aganglionic Megacolon
Vs. 05
25-06-2008
APP 21q21.3 Alzheimer disease, early-onset
Vs. 06
29-12-2008
APP 21q21.3 Alzheimer disease, early-onset
Vs. 11
05-02-2013
APP 21q21.3 Alzheimer disease, early-onset
Vs. 12
22-07-2015
APP 21q21.3 Alzheimer disease, early-onset
Vs. 13
05-02-2016
APP 21q21.3 Alzheimer disease, early-onset
Vs. 09
10-03-2008
various genes Tumours
Vs. 01
18-09-2008
various genes Tumours
Vs. 05
20-12-2012
various genes Tumours
Vs. 05
04-11-2011
CAPN3 15q15.1 Limb girdle muscular dystrophy 2A (LGMD2A)
P176-B2 Vs. 06 05-06-2012 CAPN3 15q15.1 Limb girdle muscular dystrophy 2A (LGMD2A)
P176-C1 Vs. 09 22-02-2013 CAPN3 15q15.1 Limb girdle muscular dystrophy 2A (LGMD2A)
P176-C2 Vs. 10 02-04-2014 CAPN3 15q15.1 Limb girdle muscular dystrophy 2A (LGMD2A)
P176-C3 Vs. 11 27-06-2017 CAPN3 15q15.1 Limb girdle muscular dystrophy 2A (LGMD2A)
Vs. 03
09-05-2009
CASR 3q13 Hypocalciuric Hypercalcemia, familial
Vs. 04
26-11-2010
CASR 3q13 Hypocalciuric Hypercalcemia, familial
Vs. 06
21-12-2012
CASR 3q13 Hypocalciuric Hypercalcemia, familial
Vs. 07
17-01-2014
CASR 3q13 Hypocalciuric Hypercalcemia, familial
Vs. 08
27-10-2016
CASR 3q13 Hypocalciuric Hypercalcemia, familial
Vs. 08
10-06-2009
FVIII Xq28 Haemophilia A, x-linked
Vs. 09
03-05-2010
FVIII Xq28 Haemophilia A, x-linked
Vs. 12
09-12-2012
FVIII Xq28 Haemophilia A, x-linked
Vs. 14
04-02-2016
FVIII Xq28 Haemophilia A, x-linked
Vs. 09
12-09-2011
GLI3 7p13, HOXD13 2q31, ROR2 9q22 Limb malformations
Vs. 11
10-01-2012
GLI3 7p13, HOXD13 2q31, ROR2 9q22 Limb malformations
Vs. 12
21-12-2012
GLI3 7p13, HOXD13 2q31, ROR2 9q22 Limb malformations
Vs. 13
01-03-2013
GLI3 7p13, HOXD13 2q31, ROR2 9q22 Limb malformations
Vs. 14
15-07-2015
GLI3 7p13, HOXD13 2q31, ROR2 9q22 Limb malformations